These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8070442)

  • 1. Treatment of oropharyngeal candidiasis in HIV-infected children with oral fluconazole. Multicentre Study Group [corrected].
    Marchisio P; Principi N
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):338-40. PubMed ID: 8070442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluconazole versus ketoconazole in the treatment of oropharyngeal candidiasis in HIV-infected children. Multicentre Study Group.
    Hernández-Sampelayo T
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):340-4. PubMed ID: 8070443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.
    Pons V; Greenspan D; Lozada-Nur F; McPhail L; Gallant JE; Tunkel A; Johnson CC; McCarty J; Panzer H; Levenstein M; Barranco A; Green S
    Clin Infect Dis; 1997 Jun; 24(6):1204-7. PubMed ID: 9195083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Vazquez JA; Skiest DJ; Nieto L; Northland R; Sanne I; Gogate J; Greaves W; Isaacs R
    Clin Infect Dis; 2006 Apr; 42(8):1179-86. PubMed ID: 16575739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients.
    Dronda F; Alonso-Sanz M; Laguna F; Chaves F; Martínez-Suárez JV; Rodríguez-Tudela JL; González-López A; Valencia E
    Eur J Clin Microbiol Infect Dis; 1996 Jun; 15(6):446-52. PubMed ID: 8839637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of fluconazole-refractory oropharyngeal candidiasis with itraconazole oral solution in HIV-positive patients.
    Saag MS; Fessel WJ; Kaufman CA; Merrill KW; Ward DJ; Moskovitz BL; Thomas C; Oleka N; Guarnieri JA; Lee J; Brenner-Gati L; Klausner M
    AIDS Res Hum Retroviruses; 1999 Nov; 15(16):1413-7. PubMed ID: 10555103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive resistance to fluconazole in a patient with HIV infection and recurrent oropharyngeal candidiasis].
    Corzo Delgado JE; Lozano de León F; Aretio Najarro R; Martín Mazuelos E
    Med Clin (Barc); 1994 Nov; 103(16):639. PubMed ID: 7996928
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.
    Graybill JR; Vazquez J; Darouiche RO; Morhart R; Greenspan D; Tuazon C; Wheat LJ; Carey J; Leviton I; Hewitt RG; MacGregor RR; Valenti W; Restrepo M; Moskovitz BL
    Am J Med; 1998 Jan; 104(1):33-9. PubMed ID: 9528717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.
    Laguna F; Rodríguez-Tudela JL; Martínez-Súarez JV; Polo R; Valencia E; Díaz-Guerra TM; Dronda F; Pulido F
    Clin Infect Dis; 1997 Feb; 24(2):124-30. PubMed ID: 9114134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluconazole orally dispersible tablets for the treatment of patients with oropharyngeal candidiasis.
    Vandercam B; Gibbs D; Valtonen M; Jäger H; Armignacco O
    J Int Med Res; 1998; 26(4):209-18. PubMed ID: 9818788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].
    Sow PS; Diop BM; Ndiaye I; Faye MA; Coll-Seck AM
    Dakar Med; 1993; 38(1):85-8. PubMed ID: 7882856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group.
    Pons V; Greenspan D; Debruin M
    J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1311-6. PubMed ID: 8254467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between in vitro susceptibility of Candida albicans and fluconazole-resistant oropharyngeal candidiasis in HIV-infected patients.
    Troillet N; Durussel C; Bille J; Glauser MP; Chave JP
    Eur J Clin Microbiol Infect Dis; 1993 Dec; 12(12):911-5. PubMed ID: 8187785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between in vitro resistance to fluconazole and clinical outcome of oropharyngeal candidiasis in HIV-infected patients.
    Quereda C; Polanco AM; Giner C; Sánchez-Sousa A; Pereira E; Navas E; Fortún J; Guerrero A; Baquero F
    Eur J Clin Microbiol Infect Dis; 1996 Jan; 15(1):30-7. PubMed ID: 8641300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children.
    Pienaar ED; Young T; Holmes H
    Cochrane Database Syst Rev; 2006 Jul; (3):CD003940. PubMed ID: 16856025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.
    Jandourek A; Vaishampayan JK; Vazquez JA
    AIDS; 1998 Jun; 12(9):1033-7. PubMed ID: 9662200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of single-dose fluconazole compared with a 7-day regimen of itraconazole in the treatment of AIDS-related oropharyngeal candidiasis.
    De Wit S; O'Doherty E; De Vroey C; Clumeck N
    J Int Med Res; 1998; 26(3):159-70. PubMed ID: 9718471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of oropharyngeal Candida albicans strains with reduced susceptibilities to fluconazole among human immunodeficiency virus-seropositive children and adults in a long-term care facility.
    Makarova NU; Pokrowsky VV; Kravchenko AV; Serebrovskaya LV; James MJ; McNeil MM; Lasker BA; Warnock DW; Reiss E
    J Clin Microbiol; 2003 May; 41(5):1833-7. PubMed ID: 12734213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of sargramostim (rh-GM-CSF) as adjunctive treatment of fluconazole-refractory oropharyngeal candidiasis in patients with AIDS: a pilot study.
    Vazquez JA; Hidalgo JA; De Bono S
    HIV Clin Trials; 2000; 1(3):23-9. PubMed ID: 11590502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.
    Akova M; Akalin HE; Uzun O; Hayran M; Tekuzman G; Kansu E; Aslan S; Telatar H
    Clin Infect Dis; 1994 Mar; 18(3):298-304. PubMed ID: 8011807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.